(Q42500348)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

C B Carroll

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

M-L Zeissler

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J P Zajicek

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

Neuropathology and Applied Neurobiology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

535-547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

Chemical constituents of marijuana: the complex mixture of natural cannabinoids

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Pharmacology of cannabinoid CB1 and CB2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Mechanisms compensating for dopamine loss in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

CB1 cannabinoid receptor signalling in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Endocannabinoids in basal ganglia circuits: implications for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

The endocannabinoid system as a target for the treatment of motor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

The cannabinoid system in Parkinson's disease: multiple targets to motor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabis and endocannabinoid modulators: Therapeutic promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabinoids and neuroprotection in basal ganglia disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Paraquat exposure as an etiological factor of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: involvement of p53 and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

An overview on biological mechanisms of PPARs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Troglitazone induces expression of PPARgamma in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01248.X

10.1111/J.1365-2990.2011.01248.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236282%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference